P24 Protein in Breast Cancer and Its Relation to Hormones
Author Information
Author(s): L. Seymour, W.R. Bezwoda, K. Meyer, C. Behr
Primary Institution: University of the Witwatersrand Medical School
Hypothesis
The study investigates the expression of the oestrogen-regulated protein P24 in relation to receptor status and oestrogen exposure in breast cancer.
Conclusion
P24 protein is more frequently expressed in oestrogen receptor positive breast cancers, and oestrogen treatment can induce P24 expression even in receptor negative tumors.
Supporting Evidence
- P24 protein was detected significantly more frequently in oestrogen receptor positive tumors compared to negative ones.
- After oestrogen treatment, 7 out of 13 tumors that were initially negative for P24 became positive.
- Proliferation index increased in 12 out of 19 tumors following oestrogen administration.
Takeaway
This study found that a protein called P24 is more common in certain types of breast cancer, and giving oestrogen can make some tumors that didn't have it start to show it.
Methodology
The study involved immunocytochemical assays to detect P24 protein in breast cancer specimens obtained from patients, along with flow cytometric analysis for ploidy and proliferative index.
Potential Biases
Potential bias due to the selection of patients and the methods used for receptor status determination.
Limitations
The study was limited to a specific population and may not be generalizable to all breast cancer patients.
Participant Demographics
Of the 74 patients, 20 were Caucasian and 54 were Black, with all having locally advanced primary or metastatic disease.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website